These adverse reactions may or may not be caused by the study treatments. A lot
of research is needed to know whether a treatment causes an adverse reaction.
These adverse reactions have been, and will continue to be, reviewed together
with all of the available data for AZD4635, durvalumab, and oleclumab.
The websites listed at the end of this summary may have other information about
adverse reactions or other medical problems that happened during this study.
Did any adverse reactions happen during this study?
AZD4635 with AZD4635 with
durvalumab oleclumab
(out of 29 participants) (out of 30 participants)
How many participants had adverse reactions? 82.8% (24) 83.3% (25)
How many participants had serious adverse 0.0% (0) 0.0% (0)
reactions?
How many participants stopped taking AZD4635 0.0% (0) 3.3% (1)
due to adverse reactions?
What serious adverse reactions happened during this study?
There were no serious adverse reactions during this study.
What adverse reactions happened during this study?
There were 83.1% of participants who had adverse reactions during this study. The
most common adverse reaction was nausea.
The table below shows the adverse reactions that happened in more than 1
participant. There were other adverse reactions, but these happened in only
1 participant.
10 | Clinical Study Results